ÌÇÐÄÆƽâ°æ

In 2025, the pharmaceuticals and biological products in Singapore had an industrial production index of ***. The pharmaceutical and biological industry in the country has advanced owing to the active support from the government. 

An emerging market

Singapore is home to international pharmaceutical companies, such as Pfizer, Novartis, GlaxoSmithKline, and Sanofi, which brought with them state-of-the-art manufacturing plants and world-class production capabilities. The government’s Biomedical Sciences (BMS) initiative played a major role in the advancement of drug discovery, development, and clinical research in the country. Launched in the year 2000, the initiative was established to complement the fields of electronics, chemicals, and engineering. Since its conception, it has assisted the rapid expansion of Singapore’s manufacturing output value of pharmaceutical and biological products.

Singapore’s Biopolis

Spread over *** hectares of land, Biopolis was a vision of Nobel Laureate Professor Sydney Brenner as a center of medical innovation and development. It completed the first stage of construction and was inaugurated in 2005. In the following years, the government made various investments, such as one in research and development on biomedical sciences to progress clinical research and attract business investments. This resulted in an increasing number of employees in pharmaceutical manufacturing and other related sectors in the country.